source
- Radioligand therapy gains momentum as experts discuss expanding patient impactIn a recent episode of the Denatured podcast presented by Curium, host Jennifer Smith-Parker spoke with Mike Patterson, CEO North America, and Sabine Brookman-May, Vice President and Head of Global…
- Eli Lilly partners with China’s InnoCare on drug development deal worth up to $3.35 billionEli Lilly has signed a partnership agreement with Beijing-based InnoCare to co-develop new medicines. InnoCare will apply its internal drug discovery platform while Lilly will contribute its devel…